Publicacions (332) Publicacions de MARIO FERNÁNDEZ RUIZ

2024

  1. BK polyomavirus-associated nephropathy, graft inflammation, and immunosuppression: Shedding light on the conundrum

    Transplant Infectious Disease

  2. Bacteremia due to Leuconostoc species: A 13-year single-center case series

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 3, pp. 149-151

  3. Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice

    Antiviral Research, Vol. 227

  4. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  5. How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

    Enfermedades Infecciosas y Microbiologia Clinica

  6. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation

  7. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  8. Pharmacological management of invasive mold infections in solid organ transplant recipients

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 3, pp. 239-254

  9. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

  10. Prophylactic Anticoagulation Reduces the Risk of Kidney Graft Venous Thrombosis in Recipients from Uncontrolled Donation after Circulatory Death Donors with High Renal Resistive Index

    Transplantation Direct, Vol. 10, Núm. 6, pp. E1649

  11. Reduction of Instrumentation-Related Spine Surgical Site Infections After Optimization of Surgical Techniques. A Single Center Retrospective Analysis

    Global Spine Journal, Vol. 14, Núm. 2, pp. 438-446

  12. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

    Transplant Infectious Disease, Vol. 26, Núm. 1

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  3. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  4. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

  5. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  6. Comprehensive analysis of current epidemiology, clinical features and Prognostic Factors of puerperal endometritis: A retrospective cohort analysis

    European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 18

  7. Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis

    Transplant International

  8. Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?

    Transplant International, Vol. 36